Four years after Dobbs Mifepristone again on edge of ban

Certain high risk drugs are subject to REMS - risk evaluation and mitigation strategies. The abortifacient drug Mifepristone has one such drug. But the FDA - during the administration of Joe Biden rejected such a categorization, making the drug widely accessible.

In Louisiana v. FDA the 5th Circuit Court of Appeals has issued a nationwide injunction against prescription of Mifepristone, the abortifacient drug.

 See Questions and Answers on Mifepristone for Medical Termination of PregnancyThrough Ten Weeks Gestation, FDA.